Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal

Shares of Leap Therapeutics (LPTX) climbed 25% after the microcap cancer drug developer announced a $58.9 million private investment led by Winklevoss Capital to kickstart a crypto treasury ￰0￱ investment, structured as a private placement, includes common shares and warrants priced at $0.61439 per ￰1￱ Capital, founded by Cameron and Tyler Winklevoss, will also gain two board seats at ￰2￱ which cryptos would be purchased was not disclosed. Leap, known for its immuno-oncology therapies, said it will use a portion of the capital to purchase cryptocurrency as part of a longer-term plan to hold crypto on its balance ￰3￱ rest will support clinical development of its drug ￰4￱ deal places Leap among a growing list of public companies using crypto as a treasury ￰5￱ said more details on its digital asset strategy will be announced in the near future and didn’t detail which assets it plans on ￰6￱ were higher by 25% in Monday morning trade.